Beckman Coulter announced the availability of SARS-CoV-2 IgG II Assay, a semi-quantitative COVID-19 serology tool which helps clinicians can establish a baseline to evaluate an individual&rsquo;s immune status based on the numerical value and assess relative changes in an individual&rsquo;s response to the SARS-CoV-2 virus over time.

Beckman Coulter

Brea

Beckman Coulter startup from Brea, United States is ranked 444 out of 2449 worldwide and 166 from the 748 startups in United States. See more information and additional rankings on the StartupBlink Global Ecosystem Map